Effects of endomorphins-1 and -2, endogenous μ-opioid receptor agonists, on spontaneous alternation performance in mice

European Journal of Pharmacology

Volumn 395, Issue 3, 2000, Pages 211-215

  Ukai, Makoto ^a   Watanabe, Yoshiko ^a   Kameyama, Tsutomu ^a  

^a MEIJO UNIVERSITY   (Japan)

Author keywords

Opioid receptor; (Mouse); Endomorphin 1; Endomorphin 2; Spontaneous alternation performance

Indexed keywords

BETA FUNALTREXAMINE; ENDOMORPHIN 1; ENDOMORPHIN 2; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; NALTRINDOLE; NORBINALTORPHIMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; MALE; MENTAL PERFORMANCE; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; SPATIAL MEMORY; WORKING MEMORY;

ANALGESICS, OPIOID; ANIMALS; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; NALTREXONE; NARCOTIC ANTAGONISTS; OLIGOPEPTIDES; PSYCHOMOTOR PERFORMANCE; RECEPTORS, OPIOID, MU;

EID: 0034600277     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00179-5     Document Type: Article

References (24)

1. Asakawa A., Inui A., Momose K., Ueno N., Fujino M.A., Kasuga M. Endomorphins have orexigenic and anxiolytic activities in mice. NeuroReport. 9:1998;2265-2267.
2. 5]enkephalin on passive avoidance behavior in mice. Behav. Neurosci. 99:1985;1120-1127.
3. Champion H.C., Zadina J.E., Kastin A.J., Hackler L., Ge L.-J., Kadowitz P.J. The endogenous mu-opioid receptor agonists endomorphins 1 and 2 have novel hypotensive activity in the rabbit. Biochem. Biophys. Res. Commun. 235:1997;567-570.
4. Givens B.S., Olton D.S. Cholinergic and GABAergic modulation of medial septal area: effect on working memory. Behav. Neurosci. 104:1990;849-855.
5. Haley T.J., McCormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. 12:1957;12-15.
6. + channels and adenylate cyclase. Naunyn-Schmiedeberg's Arch. Pharmacol. 345:1992;627-632.
7. Heijna M.H., Padt M., Hogenboom F., Portoghese P.S., Mulder A.H., Schoffelmeer A.N.M. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex. Eur. J. Pharmacol. 181:1990;267-278.
8. Hiller J.M., Itzhak Y., Simon E.J. Selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients. Brain Res. 406:1987;17-23.
9. Hosohata K., Burkey T.H., Alfaro-Lopez J., Varga E., Hruby V.J., Roeske W.R., Yamamura H.I. Endomorphin-1 and endomorphin-2 are partial agonists at the human μ-opioid receptor. Eur. J. Pharmacol. 346:1998;111-114.
10. Itoh J., Ukai M., Kameyama T. Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the μ-selective opioid receptor agonist DAMGO in mice. J. Pharmacol. Exp. Ther. 269:1994;15-21.
11. Izquierdo I. Effects of β-endorphin and naloxone on acquisition, memory, and retrieval of shuttle avoidance and habituation learning in rats. Psychopharmacology. 69:1980;111-115.
12. Izquierdo I., De Almeida M.A.M.R., Emiliano V.R. Unlike β-endorphin, dynorphin 1-13 does not cause retrograde amnesia for shuttle avoidance or inhibitory avoidance learning in rats. Psychopharmacology. 87:1985;216-218.
13. Izquierdo I., Netto C.A. Role of β-endorphin in behavioral regulation. Ann. N. Y. Acad. Sci. 444:1985;162-177.
14. Kameyama T., Ukai M., Shinkai N. Ameliorative effects of tachykinins on scopolamine-induced impairment of spontaneous alternation performance in mice. Methods Find. Exp. Clin. Pharmacol. 20:1998;555-560.
15. Lapchak P.A., Araujo D.M., Collier B. Regulation of endogenous acetylcholine release from mammalian brain slices by opiate receptors: hippocampus, striatum and cerebral cortex of guinea pig and rat. Neuroscience. 31:1989;313-325.
16. Nishiwaki H., Saitoh N., Nishio H., Takeuchi T., Hata F. Inhibitory effect of endomorphin-1 and 2 on acetylcholine release from myenteric plexus of guinea pig ileum. Jpn. J. Pharmacol. 78:1998;83-86.
17. Ofri D., Fan L.-Q., Simon E.J., Holler J.M. Lesioning of the nucleus basalis of Meynert has differential effects on mu, delta and kappa opioid receptor binding in rat brain: a quantitative autoradiographic study. Brain Res. 581:1992;252-260.
18. Parada-Turska J., Turski W.A. Excitatory amino acid antagonists and memory: effects of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks. Neuropharmacology. 29:1990;1111-1116.
19. Rigter H., Hannan T.J., Messing R.B., Martinez J.L. Jr., Vasquez B.J., Jensen R.A., Veliquette J., McGaugh J.L. Enkephalins interfere with acquisition of an active avoidance response. Life Sci. 26:1979;337-345.
20. Sarter M., Bodewitz G., Stephens D. Attenuation of scopolamine-induced impairment of spontaneous alternation behaviour by antagonist but not inverse agonist and agonist β-carbolines. Psychopharmacology. 94:1988;491-495.
21. Stone W.S., Walser B., Gold S.D., Gold P.E. Scopolamine- and morphine-induced impairment of spontaneous alternation performance in mice: reversal with glucose and with cholinergic and adrenergic agonists. Behav. Neurosci. 105:1991;264-271.
22. Ukai M., Kobayashi T., Kameyama T. Dynorphin A (1-13) attenuates basal forebrain-lesion-induced amnesia in rats. Brain Res. 625:1993;355-356.
23. 2, a novel dermorphin analog, impairs memory consolidation in mice. Eur. J. Pharmacol. 239:1993;237-240.
24. Zadina J.E., Hackler L., Ge L.-J., Kastin A.J. A potent and selective endogenous agonist for the μ-opiate receptor. Nature. 386:1997;499-502.